Bone regeneration using a freeze-dried 3D gradient-structured scaffold incorporating OIC-A006-loaded PLGA...

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Low-molecular-weight material OIC-A006 shows potential for tissue regeneration.
• Designing porous scaffolds is crucial for controlled cell accommodation and drug release.

Purpose of the Study:

• To fabricate a gradient-structured scaffold for controlled OIC-A006 delivery and bone regeneration.
• To evaluate the scaffold's properties, drug release kinetics, and in vitro efficacy.

Main Methods:

• Fabrication of β-TCP/PLGA scaffolds with gradient OIC-A006 loading using freeze-drying.
• Characterization of scaffold porosity, compressive strength, SEM, degradation, and in vitro drug release.
• In vitro cell culture with rat bone marrow stromal cells to assess osteogenic potential.

Main Results:

• The OIC-A006-loaded β-TCP/PLGA scaffold exhibited controlled drug release, with 10% remaining after 28 days.
• The gradient structure demonstrated slower drug release compared to normal structures.
• In vitro studies confirmed the scaffold's ability to induce adhesion and proliferation of cells towards osteoblasts.

Conclusions:

• The developed OIC-A006-loaded gradient-structured scaffold is a promising candidate for bone regeneration.
• The scaffold facilitates controlled drug delivery and supports osteogenic differentiation of cells.
• This innovative scaffold holds potential for future clinical applications in tissue regeneration.